These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 27823574

  • 21. Predictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.
    Wills AM, Li R, Pérez A, Ren X, Boyd J, NINDS NET-PD Investigators.
    J Neurol; 2017 Aug; 264(8):1746-1753. PubMed ID: 28712000
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness and safety of acupuncture combined with Madopar for Parkinson's disease: a systematic review with meta-analysis.
    Liu H, Chen L, Zhang Z, Geng G, Chen W, Dong H, Chen L, Zhan S, Li T.
    Acupunct Med; 2017 Dec; 35(6):404-412. PubMed ID: 29180347
    [Abstract] [Full Text] [Related]

  • 23. Factors associated with a placebo effect in Parkinson's disease in clinical trials: a meta-analysis.
    Haji S, Sako W, Murakami N, Osaki Y, Izumi Y.
    J Neurol; 2024 Sep; 271(9):5825-5837. PubMed ID: 38955829
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of rasagiline monotherapy for early Parkinson disease: A systematic review and meta-analysis of randomized controlled trials.
    Chang HY, Li YY, Hong CT, Kuan YC.
    J Psychopharmacol; 2022 Jun; 36(6):704-714. PubMed ID: 35546511
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.
    Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga JM, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G.
    Eur J Neurol; 2018 Jan; 25(1):120-127. PubMed ID: 28960663
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM, Pérez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J, NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.
    Olanow CW, Kieburtz K, Leinonen M, Elmer L, Giladi N, Hauser RA, Klepiskaya OS, Kreitzman DL, Lew MF, Russell DS, Kadosh S, Litman P, Friedman H, Linvah N, The P B Study Group F.
    Mov Disord; 2017 May; 32(5):783-789. PubMed ID: 28370340
    [Abstract] [Full Text] [Related]

  • 33. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors.
    Talati R, Reinhart K, Baker W, White CM, Coleman CI.
    Parkinsonism Relat Disord; 2009 Aug; 15(7):500-5. PubMed ID: 19167259
    [Abstract] [Full Text] [Related]

  • 34. Chinese medicine for idiopathic Parkinson's disease: A meta analysis of randomized controlled trials.
    Wei W, Chen HY, Fan W, Ye SF, Xu YH, Cai J.
    Chin J Integr Med; 2017 Jan; 23(1):55-61. PubMed ID: 27796824
    [Abstract] [Full Text] [Related]

  • 35. A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.
    Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N.
    BMC Neurol; 2016 May 12; 16():66. PubMed ID: 27176725
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
    Zhu ZG, Sun MX, Zhang WL, Wang WW, Jin YM, Xie CL.
    Neurol Sci; 2017 Feb 12; 38(2):215-224. PubMed ID: 27830343
    [Abstract] [Full Text] [Related]

  • 40. Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials.
    Shan CS, Zhang HF, Xu QQ, Shi YH, Wang Y, Li Y, Lin Y, Zheng GQ.
    Front Aging Neurosci; 2018 Feb 12; 10():349. PubMed ID: 30467472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.